Total Payments
$545.51
2024 Payments
$94.50
Companies
17
Transactions
30
Medicare Patients
747
Medicare Billing
$53,326
Payment Breakdown by Category
Food & Beverage$545.51 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $545.51 | 30 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $77.46 | 4 | $0 (2024) |
| Novo Nordisk Inc | $67.08 | 4 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $48.03 | 3 | $0 (2023) |
| GlaxoSmithKline, LLC. | $46.20 | 3 | $0 (2024) |
| ABBVIE INC. | $45.91 | 2 | $0 (2024) |
| Medtronic, Inc. | $32.85 | 1 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $30.21 | 2 | $0 (2023) |
| Dexcom, Inc. | $26.00 | 2 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $24.70 | 1 | $0 (2022) |
| ITI, Inc. | $23.61 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $94.50 | 5 | Sumitomo Pharma America, Inc. ($22.11) |
| 2023 | $150.84 | 9 | Novo Nordisk Inc ($33.46) |
| 2022 | $300.17 | 16 | Lilly USA, LLC ($39.57) |
All Payment Transactions
30 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: VACCINES | ||||||
| 11/13/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $22.11 | General |
| Category: HORMONE THERAPY | ||||||
| 06/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: Gastroenterology | ||||||
| 04/26/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: Diabetes | ||||||
| 03/20/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: NEUROSCIENCE | ||||||
| 10/05/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Diabetes | ||||||
| 03/21/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: Respiratory | ||||||
| 03/21/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: Endocrinology | ||||||
| 02/28/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/21/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Obesity | ||||||
| 02/14/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Inflammation | ||||||
| 02/02/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: Diabetes | ||||||
| 01/30/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: DIABETES | ||||||
| 01/10/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/12/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $25.34 | General |
| Category: Diabetes | ||||||
| 12/05/2022 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $12.58 | General |
| Category: Endocrinology | ||||||
| 11/17/2022 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BEXSERO | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: VACCINES | ||||||
| 10/25/2022 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $32.85 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/24/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: Diabetes | ||||||
| 09/23/2022 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BEXSERO, FLULAVAL QUADRIVALENT | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: VACCINES | ||||||
| 09/05/2022 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: Neuroscience | ||||||
| 09/01/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.09 | General |
| Category: NEUROSCIENCE | ||||||
| 08/09/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $12.56 | General |
| Category: PRIMARY CARE | ||||||
| 08/04/2022 | Merck Sharp & Dohme LLC | BELSOMRA (Drug), JANUVIA, STEGLUJAN | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: NEUROSCIENCE | ||||||
| 07/14/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 390 | 423 | $62,961 | $21,528 |
| 2022 | 2 | 81 | 130 | $27,957 | $9,706 |
| 2021 | 4 | 123 | 180 | $32,723 | $12,084 |
| 2020 | 7 | 153 | 190 | $31,568 | $10,009 |
Total Patients
747
Total Services
923
Medicare Billing
$53,326
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 219 | 245 | $36,750 | $13,518 | 36.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 57 | 61 | $13,359 | $3,748 | 28.1% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 59 | 60 | $8,970 | $2,745 | 30.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 29 | 31 | $2,790 | $1,096 | 39.3% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 26 | 26 | $1,092 | $421.20 | 38.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 50 | 99 | $20,889 | $6,322 | 30.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 31 | 31 | $7,068 | $3,383 | 47.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 53 | 103 | $21,012 | $7,107 | 33.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 28 | 28 | $6,188 | $3,133 | 50.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 28 | 35 | $4,865 | $1,610 | 33.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 14 | 14 | $658.00 | $234.93 | 35.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 49 | 74 | $14,652 | $3,657 | 25.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 28 | 28 | $5,992 | $2,738 | 45.7% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 12 | 14 | $3,080 | $929.74 | 30.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 16 | 20 | $2,937 | $911.17 | 31.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 21 | 25 | $3,350 | $779.81 | 23.3% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 11 | 12 | $792.00 | $713.49 | 90.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 16 | 17 | $765.00 | $279.36 | 36.5% |
About Katherine Figura, FNP
Katherine Figura, FNP is a Family healthcare provider based in Chesterfield, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2012. The National Provider Identifier (NPI) number assigned to this provider is 1922363456.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Katherine Figura, FNP has received a total of $545.51 in payments from pharmaceutical and medical device companies, with $94.50 received in 2024. These payments were reported across 30 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($545.51).
As a Medicare-enrolled provider, Figura has provided services to 747 Medicare beneficiaries, totaling 923 services with total Medicare billing of $53,326. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Chesterfield, MO
- Active Since 07/11/2012
- Last Updated 05/16/2023
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1922363456
Products in Payments
- Ozempic (Drug) $50.35
- SHINGRIX (Biological) $46.20
- MOUNJARO (Drug) $42.19
- JARDIANCE (Drug) $41.97
- LEQVIO (Drug) $33.56
- INTELLIS ADAPTIVESTIM (Device) $32.85
- VRAYLAR (Drug) $28.09
- Dexcom G6 Transmitter (Medical Supply) $26.00
- JYNARQUE (Drug) $24.70
- CAPLYTA (Drug) $23.61
- MYFEMBREE (Drug) $22.11
- BELSOMRA (Drug) $19.25
- QULIPTA (Drug) $17.82
- XARELTO (Drug) $17.22
- Wegovy (Drug) $16.73
- FASENRA (Biological) $16.41
- Otezla (Drug) $16.36
- XIFAXAN (Drug) $15.03
- ENTRESTO (Drug) $14.47
- EMGALITY (Drug) $14.23
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Chesterfield
Jared Hu, Fnp-Bc, FNP-BC
Family — Payments: $20,726
Family $20,726
Whitney Feichtner, Fnp, FNP
Family — Payments: $15,487
Family $15,487
Jessica Kemp
Family — Payments: $10,518
Family $10,518
Christine Mathews, Aprn, Fnp-Bc, APRN, FNP-BC
Family — Payments: $7,177
Family $7,177
Scott Thouvenot
Family — Payments: $6,024
Family $6,024
Hannah Powers
Family — Payments: $3,610
Family $3,610